Deconstructing SARS‐CoV‐2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Vincenzo Tragni und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy-Pharmaceutical Sciences, University of Bari, Bari, Italy. Hauptthemen laut MEDLINE: Single-Domain Antibodies, COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Since 2020 the COVID‐19 pandemic has led scientists to search for strategies to predict the transmissibility and virulence of new severe acute respiratory syndrome coronavirus 2 variants based on the estimation of the affinity of the spike receptor binding domain (RBD) for the human angiotensin‐converting enzyme 2 (ACE2) receptor and/or neutralizing antibodies. In this context, our lab developed a computational pipeline to quickly quantify the free energy of interaction at the spike RBD/ACE2 protein–protein interface, reflecting the incidence trend observed in the transmissibility/virulence of the investigated variants. In this new study, we used our pipeline to estimate the free energy of interaction between the RBD from 10 variants, and 14 antibodies (ab), or 5 nanobodies (nb), highlighting the RBD regions preferentially targeted by the investigated ab/nb. Our structural comparative analysis and interaction energy calculations allowed us to propose the most promising RBD regions to be targeted by future ab/nb to be designed by site‐directed mutagenesis of existing high‐affinity ab/nb, to increase their affinity for the target RBD region, for preventing spike‐RBD/ACE2 interactions and virus entry in host cells. Furthermore, we evaluated the ability of the investigated ab/nb to simultaneously interact with the three RBD located on the surface of the trimeric spike protein, which can alternatively be in up‐ or down‐ (all‐3‐up‐, all‐3‐down‐, 1‐up‐/2‐down‐, 2‐up‐/1‐down‐) conformations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari, Bari, Italy.
- Department of Biosciences, Biotechnologies, Environment, University of Bari, Bari, Italy.
- Department of Veterinary Medicine, University of Bari, Valenzano, Italy.
ORCID-Profile: Ciro Leonardo Pierri
Zitieren
APA
Tragni, V., Mercurio, I., Paoletti, D. P., Onofrio, A., Laera, L., Cafferati Beltrame, L., Sgobba, M. N., Guerra, L., Volpicella, M., De Grassi, A., Elia, G., & Pierri, C. L. (2023). Deconstructing SARS‐CoV‐2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD. Journal of Medical Virology. https://doi.org/10.1002/jmv.28875
Vancouver
Tragni V, Mercurio I, Paoletti DP, Onofrio A, Laera L, Cafferati Beltrame L, et al. Deconstructing SARS‐CoV‐2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD. Journal of Medical Virology. 2023. doi:10.1002/jmv.28875
BibTeX
@article{Tragni2023,
author = {Tragni, Vincenzo and Mercurio, Ivan and Paoletti, Diletta Pia and Onofrio, Angelo and Laera, Luna and Cafferati Beltrame, Lucas and Sgobba, Maria Noemi and Guerra, Lorenzo and Volpicella, Mariateresa and De Grassi, Anna and Elia, Gabriella and Pierri, Ciro Leonardo},
title = {Deconstructing SARS‐CoV‐2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28875}
}
EUVIMED